Clinical features of systemic amyloidosis: a scoping review.
Pubblicato: 2026-07-28
Blood advances
Medical Digest Indicizzato: 2026-07-29
(Summary generation failed. Please refer to the original article.)
Leggi su PubMedLe pubblicazioni più impattanti della settimana in 29 specialità, curate dall'IA
Ultimo aggiornamento: 28 lug 2026
Pubblicato: 2026-07-28
Blood advances
Medical Digest Indicizzato: 2026-07-29
(Summary generation failed. Please refer to the original article.)
Leggi su PubMedPubblicato: 2026-07-28
Cancer letters
Medical Digest Indicizzato: 2026-07-29
(Summary generation failed. Please refer to the original article.)
Leggi su PubMedPubblicato: 2026-07-27
Cell reports
Medical Digest Indicizzato: 2026-07-29
This study identifies GBP6 as a mitochondrial factor associated with aggressive cervical cancer, enriched in high-risk tumors and correlating with poor clinical outcomes. GBP6 knockdown suppresses tumor cell proliferation and promotes cell death by disrupting mitochondrial bioenergetics and induc...
Leggi su PubMedPubblicato: 2026-07-27
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Medical Digest Indicizzato: 2026-07-29
This study focuses on reprogramming myofibroblastic cancer-associated fibroblasts (CAFs) into immune activated antigen presenting CAFs (apCAFs) as a treatment for fibrotic breast cancer. Using a spatiotemporally ultrasound-controlled nanoparticle, the researchers successfully reprogrammed myCAFs ...
Leggi su PubMedPubblicato: 2026-07-27
Journal for immunotherapy of cancer
Medical Digest Indicizzato: 2026-07-29
This study explores the role of mitophagy in cancer immunogenicity, identifying TOMM40 as a gatekeeper of mitochondrial import that restrains mitophagy. Loss of TOMM40 induces mitochondrial dysfunction and hyperactivated mitophagy, converting immune-cold tumors into immune-inflamed states with in...
Leggi su PubMedMedici di tutto il mondo iniziano la giornata con revisioni della letteratura curate dall'IA, consegnate alle 7.
Prova gratuita di 14 giorni